When does seasonal affective disorder typically occur?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When Does Seasonal Affective Disorder Typically Occur?

Seasonal affective disorder (SAD) typically occurs during autumn or winter months, with symptoms beginning in fall and continuing through winter, followed by full remission in spring or summer. 1

Temporal Pattern

The characteristic timing of SAD follows a predictable seasonal cycle:

  • Onset: Symptoms typically begin in autumn (fall) as daylight hours decrease 2, 3
  • Peak: Depression continues throughout winter months when daylight is shortest 1
  • Remission: Full symptom resolution occurs in spring or summer as daylight hours increase 2, 4

Clinical Timing for Treatment Initiation

Based on the most recent guideline evidence, the temporal pattern has important treatment implications:

Preventive treatment should begin in September, or at least 2-4 weeks before the expected onset of depressive symptoms each year 1. This proactive approach allows clinicians to intervene before the full depressive episode develops.

For established SAD, treatment should be initiated in autumn with first onset of symptoms and continued through the winter months until spring or summer returns 1. Discontinuing treatment during winter frequently leads to relapse, so continuation throughout the entire at-risk season is essential.

Diagnostic Requirements

The temporal nature is so fundamental to SAD that diagnosis requires:

  • Two consecutive years of episodes occurring in the same season 2
  • Full remission when the specified season ends 2

This strict temporal criterion distinguishes SAD from non-seasonal depression and ensures the diagnosis reflects true seasonal variation rather than coincidental timing.

Less Common Variant

While the vast majority of SAD occurs in fall/winter, a less common variant causes depression in spring or early summer 3. However, this represents a minority of cases, and the winter pattern remains the defining characteristic of SAD.

Geographic Considerations

The prevalence and severity of SAD correlates with latitude, ranging from 1.5% to 9% depending on distance from the equator 5. Those living farther north experience more pronounced seasonal light variation and correspondingly higher SAD rates 2.

Related Questions

What are the recommended pharmacological interventions for seasonal affective disorder (SAD) beyond increased sunlight exposure and vitamin D supplementation?
What has the strongest evidence for long‑term prevention of seasonal affective disorder recurrence after treatment and symptom remission?
Can lamotrigine (anticonvulsant) be used to treat a patient with seasonal affective disorder (SAD) who has not responded to first-line therapies such as light therapy or selective serotonin reuptake inhibitors (SSRIs)?
What is the proper dosage and usage of Wellbutrin (bupropion) for treating depression and seasonal affective disorder?
What is the best practice for augmenting escitalopram in a 27‑year‑old patient who has been taking escitalopram 20 mg daily for 2½ months and continues to have marked anxiety, insomnia, and reduced pleasure?
How should a patient taking hydrocodone 10 mg five times daily be transitioned to a buprenorphine (Subutex) transdermal patch?
What birth control method is recommended for a healthy woman of reproductive age to use during travel, considering convenience and safety?
How should an otherwise healthy adult with mild airspace disease on chest imaging be managed?
Why take bumetanide (Bumex) and furosemide (Lasix) together rather than increasing the dose of a single loop diuretic?
In a 63-year-old man taking furosemide (Lasix), metformin (Glucophage), insulin glargine (Lantus Solostar), tirzepatide (Mounjaro), lisinopril, hydrochlorothiazide (Hydrodiuril), naloxone (Narcan), empagliflozin (Jardiance), cholecalciferol (vitamin D3), aspirin, atorvastatin (Lipitor), budesonide‑formoterol (Symbicort), ibuprofen, gabapentin (Neurontin), and various medical supplies, which of these medications are associated with an increased risk of nephrolithiasis (kidney stones)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.